Eden Research plc
EDNSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4,303 | $3,192 | $1,827 | $1,229 |
| % Growth | 34.8% | 74.7% | 48.7% | – |
| Cost of Goods Sold | $2,430 | $1,427 | $1,620 | $1,200 |
| Gross Profit | $1,872 | $1,765 | $207 | $28 |
| % Margin | 43.5% | 55.3% | 11.3% | 2.3% |
| R&D Expenses | $0 | $0 | $284 | $215 |
| G&A Expenses | $3,510 | $2,998 | $2,749 | $2,694 |
| SG&A Expenses | $3,510 | $2,998 | $2,774 | $3,237 |
| Sales & Mktg Exp. | $0 | $0 | $25 | $542 |
| Other Operating Expenses | $548 | $635 | $0 | $0 |
| Operating Expenses | $4,058 | $3,632 | $2,774 | $3,237 |
| Operating Income | -$2,186 | -$1,867 | -$2,567 | -$3,208 |
| % Margin | -50.8% | -58.5% | -140.5% | -261.1% |
| Other Income/Exp. Net | $6 | -$5,054 | -$1 | -$187 |
| Pre-Tax Income | -$2,180 | -$6,920 | -$2,536 | -$3,338 |
| Tax Expense | -$267 | -$428 | -$324 | -$618 |
| Net Income | -$1,907 | -$6,494 | -$2,237 | -$2,789 |
| % Margin | -44.3% | -203.5% | -122.4% | -227% |
| EPS | -0.004 | -0.015 | -0.006 | -0.007 |
| % Growth | 76.6% | -161% | 19.2% | – |
| EPS Diluted | -0.004 | -0.015 | -0.006 | -0.007 |
| Weighted Avg Shares Out | 533,353 | 420,939 | 380,549 | 380,340 |
| Weighted Avg Shares Out Dil | 533,353 | 420,921 | 380,549 | 380,340 |
| Supplemental Information | – | – | – | – |
| Interest Income | $110 | $34 | $0 | $0 |
| Interest Expense | $10 | $17 | $22 | $32 |
| Depreciation & Amortization | $583 | $625 | $687 | $590 |
| EBITDA | -$1,587 | -$6,245 | -$1,858 | -$2,715 |
| % Margin | -36.9% | -195.6% | -101.7% | -221% |